BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29699569)

  • 1. Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP
    Wang F; Wang X; Abskharon R; Ma J
    Acta Neuropathol Commun; 2018 Apr; 6(1):30. PubMed ID: 29699569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment.
    Shan Z; Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    Prion; 2016 Jul; 10(4):305-18. PubMed ID: 27565564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin.
    Cronier S; Gros N; Tattum MH; Jackson GS; Clarke AR; Collinge J; Wadsworth JD
    Biochem J; 2008 Dec; 416(2):297-305. PubMed ID: 18684106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
    Timmes AG; Moore RA; Fischer ER; Priola SA
    PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of guanidine on proteinase K resistance in vitro and infectivity of scrapie prion protein PrP(Sc).
    Gao JM; Zhou XB; Xiao XL; Zhang J; Chen L; Gao C; Zhang BY; Dong XP
    Acta Virol; 2006; 50(1):25-32. PubMed ID: 16599182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
    Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
    Prion; 2015; 9(5):394-403. PubMed ID: 26555211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinase K and the structure of PrPSc: The good, the bad and the ugly.
    Silva CJ; Vázquez-Fernández E; Onisko B; Requena JR
    Virus Res; 2015 Sep; 207():120-6. PubMed ID: 25816779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PK-sensitive PrP is infectious and shares basic structural features with PK-resistant PrP.
    Sajnani G; Silva CJ; Ramos A; Pastrana MA; Onisko BC; Erickson ML; Antaki EM; Dynin I; Vázquez-Fernández E; Sigurdson CJ; Carter JM; Requena JR
    PLoS Pathog; 2012; 8(3):e1002547. PubMed ID: 22396643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of bacterially expressed recombinant prion protein.
    Wang F; Wang X; Ma J
    Methods; 2011 Mar; 53(3):208-13. PubMed ID: 21176786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical Characterization of Prions.
    Fiorini M; Bongianni M; Monaco S; Zanusso G
    Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.
    Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P
    J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new mechanism for transmissible prion diseases.
    Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Ostapchenko VG; Budka H; Rohwer RG; Baskakov IV
    J Neurosci; 2012 May; 32(21):7345-55. PubMed ID: 22623680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions.
    Wang F; Yang F; Hu Y; Wang X; Wang X; Jin C; Ma J
    Biochemistry; 2007 Jun; 46(23):7045-53. PubMed ID: 17503780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
    Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
    Prion; 2014; 8(4):314-8. PubMed ID: 25482603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease.
    Zou WQ; Capellari S; Parchi P; Sy MS; Gambetti P; Chen SG
    J Biol Chem; 2003 Oct; 278(42):40429-36. PubMed ID: 12917418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
    Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
    PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
    Kim DH; Lee HM; Ryou C
    J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid.
    D'Castro L; Wenborn A; Gros N; Joiner S; Cronier S; Collinge J; Wadsworth JD
    PLoS One; 2010 Dec; 5(12):e15679. PubMed ID: 21187933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.